Abarelix, Structure, Mechanism of Action, Drug Interactions, Therapeutic Uses, Adverse effects
Abarelix Abarelix is a medication used in the treatment of advanced hormone-sensitive prostate cancer in men. It belongs to a class of drugs known as gonadotropin-releasing hormone (GnRH) antagonists. Prostate cancer growth is often stimulated by hormones, particularly testosterone. GnRH antagonists work by blocking the action of GnRH in the body, which leads to a decrease in testosterone production. Lowering testosterone levels can slow down the progression of prostate cancer and alleviate symptoms. The common brand name for Abarelix is " Plenaxis ". Mechanism Of Action The Mechanism of Action of Abarelix involves its role as a gonadotropin-releasing hormone (GnRH) antagonist. GnRH is a hormone produced in the hypothalamus of the brain and acts on the pituitary gland to stimulate the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). These hormones, in turn, stimulate the testes to produce testosterone. In the case of advanced hormone-sensitive p...